Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Karolinska Institutet | OTHER |
| Örebro University, Sweden | OTHER |
| Umeå University | OTHER |
| Göteborg University |
Not provided
Not provided
Not provided
Not provided
This study is aimed to validate the questionnaire called Pediatric Sleep Questionnaire on a Swedish cohort of children from 18 months to 15 years old with obstructive sleep disordered breathing.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| PSQ-cohort | Patients recruited from Akademiska Sjukhuset, Örebro, Västra Götaland, Skåne, Stockholm and Umeå. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Pediatric Sleep Questionnaire | Diagnostic Test | Questionnaire with 22 questions of symptoms of OSDB |
|
| Measure | Description | Time Frame |
|---|---|---|
| Level of baseline PSQ | Level of baseline PSQ of children who are referred to surgery. A level of >33% yes i.e. 8/22 indicates medium to severe OSA and less than five yes indicates a healthy status. Minimum is 0 yes and maximum is 22 where 22 is the most severe disease. PSQ has a score from 0 to 22 where every yes on the scale is one point. A level of 8 "yes" (>33%) indicates moderate to severe OSDB and less than five indicates no OSDB. | Baseline |
| Changes of baseline PSQ after treatment | Changes of baseline PSQ with 6 months follow-up, after treatment/surgery | 6 months to 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| PSQ vs OSA-18 | Compare PSQ-levels with OSA-18 levels OSA-18 is accounted as a scale from 18 to 126 points where a higher rate is a more severe disease. Score less than 60 suggests a mild impact on quality of life. Scores between 60 and 80 a moderate impact and a score higher than 80 severe impact. OSA-18 has a summary of 18 - 126 points where a higher level indicates worse quality of life. A score less than 60 indicates a mild impact on quality of life and score between 60 and 80 indicates moderate impact whereas a score above 80 indicates a high impact. |
| Measure | Description | Time Frame |
|---|---|---|
| 5 and 10 years follow-up | PSQ and OSA-18 compared to baseline and after 6months compared to levels at 5 and 10 years follow-up | 11 years |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
The study population will be included from the ENT-clinics or the waiting lists to surgical treatments.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Isabella Sjölander | Contact | 018-6110000 | isabella.sjolander@uu.se |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Akademiska hospital | Recruiting | Uppsala | Sweden |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D020181 | Sleep Apnea, Obstructive |
| D012893 | Sleep Wake Disorders |
| ID | Term |
|---|---|
| D012891 | Sleep Apnea Syndromes |
| D001049 | Apnea |
| D012120 | Respiration Disorders |
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided
| OTHER |
Not provided
Not provided
Not provided
| 6 months |
| PSQ vs. PSG | PSQ-levels compared to Polysomnography outcomes | 6 months |
| PSQ levels of healthy controls vs children with OSDB | Compare the PSQ-levels of children with OSDB-symptoms to children without OSDB-symptoms | 6 months |
| D020919 |
| Sleep Disorders, Intrinsic |
| D020920 | Dyssomnias |
| D009422 | Nervous System Diseases |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D001523 | Mental Disorders |